07:00 , Aug 5, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Heart failure Regulator of G-protein signaling 5 (RGS5); MAP kinase kinase 1 (MAP2K1; MEK1); MAP kinase 3 (MAPK3; ERK-1); MAPK1 (ERK-2) Mouse studies suggest...
07:00 , May 1, 2008 |  BC Innovations  |  Targets & Mechanisms

Opening a Door into Solid Tumors

The irregular and leaky vasculature of tumors has been a major obstacle to the effective delivery of chemotherapeutics and immunotherapies to the cancerous tissues they target. 1 A paper in Nature now suggests that inhibiting...
07:00 , Sep 7, 1999 |  BC Week In Review  |  Company News

Cadus Pharmaceutical Corp. other research news

KDUS researchers published in Nature Biotechnology yeast-based genetic screens that are designed to identify mammalian non-receptor proteins that modulate G-protein signaling. The screens involve yeast whose growth is conditional upon either activation or inactivation of...